DLL4 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

77 results for “DLL4”

Trials

View all 30 →

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

60 participants · First posted Mar 9, 2026

Not yet recruiting

DLL3 CAR-T Therapy Targeting Brain Tumors

30 participants · First posted Sep 18, 2025

Imaging of Solid Tumors Using DLL3 SPECT

45 participants · First posted Jul 7, 2025

Drugs

View all 16 →

Anti-DLL4 antibody(Regeneron)

DLL4-Fc protein(Regeneron)

Investigational

Dilpacimab

News

View all 31 →

Compass Therapeutics Receives FDA Fast Track Designation for CTX-009 Bispecific Antibody

Compass Therapeutics Advances Pipeline with New Bispecific Antibody Candidate

Compass Therapeutics Reports Promising Clinical Data Across Bispecific Antibody Pipeline

Page 1 of 8